{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:47:18Z","timestamp":1792849638282,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,17]]},"DOI":"10.7759\/cureus.35094","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T09:59:46Z","timestamp":1676627986000},"source":"Crossref","is-referenced-by-count":9,"title":["Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Wael  T","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Jahagirdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifrah","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell","family":"Clarkston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Likhitsup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz G","year":"2002","unstructured":"Ostapowicz G, Fontana RJ, Schi\u00f8dt FV, et al.. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002, 137:947-54. 10.7326\/0003-4819-137-12-200212170-00007","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"Garcia-Cortes M","year":"2020","unstructured":"Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update. Arch Toxicol. 2020, 94:3381-407. 10.1007\/s00204-020-02885-1","journal-title":"Arch Toxicol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-6-s104","article-title":"Drug-induced liver injury","volume":"16","author":"Katarey D","year":"2016","unstructured":"Katarey D, Verma S. Drug-induced liver injury. Clin Med (Lond). 2016, 16:104-9. 10.7861\/clinmedicine.16-6-s104","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - types and phenotypes","volume":"381","author":"Hoofnagle JH","year":"2019","unstructured":"Hoofnagle JH, Bj\u00f6rnsson ES. Drug-induced liver injury - types and phenotypes. N Engl J Med. 2019, 381:264-73. 10.1056\/NEJMra1816149","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani N","year":"2008","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, et al.. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008, 135:1924-34, 1934.e1-4. 10.1053\/j.gastro.2008.09.011","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"Association of liver injury from specific drugs, or groups of\u00a0drugs, with polymorphisms in HLA and other genes in a\u00a0genome-wide association study","volume":"152","author":"Nicoletti P","year":"2017","unstructured":"Nicoletti P, Aithal GP, Bjornsson ES, et al.. Association of liver injury from specific drugs, or groups of\u00a0drugs, with polymorphisms in HLA and other genes in a\u00a0genome-wide association study. Gastroenterology. 2017, 152:1078-89. 10.1053\/j.gastro.2016.12.016","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani N","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al.. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015, 148:1340-52.e7. 10.1053\/j.gastro.2015.03.006","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct","volume":"32","author":"Fontana RJ","year":"2009","unstructured":"Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009, 32:55-68. 10.2165\/00002018-200932010-00005","journal-title":"Drug Saf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan G","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993, 46:1323-30. 10.1016\/0895-4356(93)90101-6","journal-title":"J Clin Epidemiol"},{"key":"ref10","article-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]","year":"2012","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja AJ","year":"2011","unstructured":"Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011, 56:958-76. 10.1007\/s10620-011-1611-4","journal-title":"Dig Dis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: drug-induced liver injury","volume":"70","year":"2019","unstructured":"EASL Clinical Practice Guidelines. drug-induced liver injury. J Hepatol. 2019, 70:1222-61. 10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0214-RA","article-title":"Drug-induced liver Injury","volume":"139","author":"Fisher K","year":"2015","unstructured":"Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver Injury. Arch Pathol Lab Med. 2015, 139:876-87. 10.5858\/arpa.2014-0214-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury","author":"Fontana RJ","year":"2022","unstructured":"Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W, Navarro V. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2022, 10.1002\/hep.32689","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner DE","year":"2014","unstructured":"Kleiner DE, Chalasani NP, Lee WM, et al.. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology. 2014, 59:661-70. 10.1002\/hep.26709","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2018.09.006","article-title":"Selective androgen receptor modulators: current knowledge and clinical applications","volume":"7","author":"Solomon ZJ","year":"2019","unstructured":"Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Selective androgen receptor modulators: current knowledge and clinical applications. Sex Med Rev. 2019, 7:84-94. 10.1016\/j.sxmr.2018.09.006","journal-title":"Sex Med Rev"},{"key":"ref17","unstructured":"FDA issues warning about body-building products labeled to contain steroid and steroid-like substances. (2017). Accessed. 2022: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-issues-warning-about-body-building-products-labeled-contai...."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17069","article-title":"Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the Internet","volume":"318","author":"Van Wagoner RM","year":"2017","unstructured":"Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the Internet. JAMA. 2017, 318:2004-10. 10.1001\/jama.2017.17069","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1456","article-title":"Drug-induced liver injury by selective androgenic receptor modulators","volume":"4","author":"Flores JE","year":"2020","unstructured":"Flores JE, Chitturi S, Walker S. Drug-induced liver injury by selective androgenic receptor modulators. Hepatol Commun. 2020, 4:450-2. 10.1002\/hep4.1456","journal-title":"Hepatol Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000370","article-title":"Ligandrol (LGD-4033)-induced liver injury","volume":"7","author":"Barbara M","year":"2020","unstructured":"Barbara M, Dhingra S, Mindikoglu AL. Ligandrol (LGD-4033)-induced liver injury. ACG Case Rep J. 2020, 7:10.14309\/crj.0000000000000370","journal-title":"ACG Case Rep J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i16.4062","article-title":"Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review","volume":"9","author":"Koller T","year":"2021","unstructured":"Koller T, Vrbova P, Meciarova I, Molcan P, Smitka M, Adamcova Selcanova S, Skladany L. Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review. World J Clin Cases. 2021, 9:4062-71. 10.12998\/wjcc.v9.i16.4062","journal-title":"World J Clin Cases"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000518","article-title":"Drug-induced liver injury from enobosarm (Ostarine), a selective androgen receptor modulator","volume":"8","author":"Bedi H","year":"2021","unstructured":"Bedi H, Hammond C, Sanders D, Yang HM, Yoshida EM. Drug-induced liver injury from enobosarm (Ostarine), a selective androgen receptor modulator. ACG Case Rep J. 2021, 8:10.14309\/crj.0000000000000518","journal-title":"ACG Case Rep J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel RL","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022, 72:7-33. 10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0670","article-title":"Selective androgen receptor modulator RAD140 inhibits the growth of androgen\/estrogen receptor-positive breast cancer models with a distinct mechanism of action","volume":"23","author":"Yu Z","year":"2017","unstructured":"Yu Z, He S, Wang D, et al.. Selective androgen receptor modulator RAD140 inhibits the growth of androgen\/estrogen receptor-positive breast cancer models with a distinct mechanism of action. Clin Cancer Res. 2017, 23:7608-20. 10.1158\/1078-0432.CCR-17-0670","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7200","article-title":"Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models","volume":"14","author":"Morimoto M","year":"2017","unstructured":"Morimoto M, Aikawa K, Hara T, Yamaoka M. Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models. Oncol Lett. 2017, 14:8066-71. 10.3892\/ol.2017.7200","journal-title":"Oncol Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/138099-selective-androgen-receptor-modulators-sarms-induced-liver-injury-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:46Z","timestamp":1707508306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/138099-selective-androgen-receptor-modulators-sarms-induced-liver-injury-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.35094","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,17]]}}}